Wire · opportunities
Science Corporation’s brain tech is worth $3.5 billion after new funding
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 17 November 2026 · Fusion42 review
Science Corporation raised $400 million in Series D funding, valuing the company at $3.5 billion. The startup develops a wearable and implantable chip to restore vision for age-related macular degeneration and plans to seek FDA approval to expand use in the US, while also preparing trials for brain-related treatments.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
Your Medtech startup should track Science Corporation’s FDA approach as it opens US access to rare-condition vision tech, setting a precedent for similar brain-implant devices. This funding jump signals growing investor confidence and a clearer path to clinical trials for neurotech treatments.
◆ Coverage
1 source · 17 Nov 2026
◆ Related on Wire
◆ Topics